Evidence map›Paper›PMID 29486058›Full record

ArticleBritish journal of pharmacology2018

Antinociceptive effects of novel histamine H

Katarzyna Popiolek-Barczyk, Dorota Łażewska, Gniewomir Latacz, Agnieszka Olejarz, Wioletta Makuch, Holger Stark, Katarzyna Kieć-Kononowicz, Joanna Mika

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. AR71, Histamine HInternational journal of molecular sciences · 2024
    Article
  2. Article
  3. Article
  4. Dual Piperidine-Based Histamine HJournal of medicinal chemistry · 2023
    Article
  5. Trisubstituted 1,3,5-Triazines as Histamine HMolecules (Basel, Switzerland) · 2023
    Article
  6. Article
  7. The Histamine HInternational journal of molecular sciences · 2022
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Novel Analgesics with Peripheral Targets.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
  16. Review
  17. Are the Hydantoin-1,3,5-triazine 5-HTMolecules (Basel, Switzerland) · 2019
    Article
  18. The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HTInternational journal of molecular sciences · 2019
    Article
  19. Review
  20. Antinociceptive effects of novel histamine HBritish journal of pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Katarzyna Popiolek-BarczykDepartment of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Krakow, Poland.ORCID 0000-0003-4366-6577
Dorota ŁażewskaDepartment of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Krakow, Poland.
Gniewomir LataczDepartment of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Krakow, Poland.
Agnieszka OlejarzDepartment of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Krakow, Poland.
Wioletta MakuchDepartment of Pain Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Holger StarkInstitute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID 0000-0003-3336-1710
Katarzyna Kieć-KononowiczDepartment of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Krakow, Poland.
Joanna MikaDepartment of Pain Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.ORCID 0000-0003-1986-7205
Jagiellonian University · PLMaj Institute of Pharmacology · PLHeinrich Heine University Düsseldorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe histaminergic system is a promising target for the development of new analgesics, as histamine H EXPERIMENTAL APPROACH: We used chronic constriction injury (CCI) to the sciatic nerve in mice to model neuropathy. Effects of a new H KEY

resultsE-162 and TR-7 attenuated nociceptive responses and profound morphine analgesia in males with CCI. These antagonists showed analgesia in naive mice (tail flick test) and produced prolonged analgesia in neuropathic females. E-162-induced analgesia was reversed by pyrilamine, an H CONCLUSIONS AND IMPLICATIONS: We describe a therapeutic use for new H

Indexed as

AnalgesiaAnalgesics, OpioidAnimalsDrug SynergismDrug Therapy, CombinationFemaleHistamine AntagonistsMaleMiceMorphineNeuralgiaReceptors, Histamine H3Receptors, Histamine H4Sciatic NerveAnalgesics, OpioidHistamine AntagonistsMorphineReceptors, Histamine H3Receptors, Histamine H4

Identifiers

PMID29486058
PMCPMC6016676
OpenAlexW2792390010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.